Comvita Limited · NZX:CVT
Comvita — Shareholder Meeting (2015)
28 slides from Comvita's shareholder meeting presentation, 2015
Slide 1: Annual Shareholder Meeting 2015
2015 ANNUAL SHAREHOLDER MEETING
Slide 2: Welcome and Agenda
Annual Shareholder Meeting 2015 WELCOME AND AGENDA 1. Welcome / Apologies – Neil Craig 2. Chairman’s Review – Neil Craig 3. CEO Review – Bre@ Hewle@ 4. ResoluDon 1: Reports and Financial Statements 5. ResoluDon 2: Appointment and RemuneraDon of Auditors 6. ResoluDons 3 – 5: Director’s ElecDons 7. Re
Slide 3: Annual Shareholder Meeting 2015
Annual Shareholder Meeting 2015 33
Slide 4: Key Achievements Long Term
Annual Shareholder Meeting 2015 KEY ACHIEVEMENTS LONG TERM • Establishment of a business model and strategy designed to get us to $400m in Revenue by 2020, with sustained earnings growth • Strong Leadership; Management and Board • VerDcal IntegraDon Strategy to be@er control source of supply • Sell
Slide 5: Financial Performance
Annual Shareholder Meeting 2015 FINANCIAL PERFORMANCE $153m Group Revenue EBITDA** $23.0m $115m $103m $96m $17.0m $15.5m $85m $14.7m $82m $71m $11.2m $57m* $39m $6.3m $5.3m $4.8m $0.4m* 2015 2006 2008 2009 2010 2011 2012 2013 2014 2015 2006 2008 2009 2010 2011 2012 2013 2014 5 * 15 month period, due
Slide 6: Shareholder Communications
Annual Shareholder Meeting 2015 SHAREHOLDER COMMUNICATIONS • NZX Announcements • Investor PresentaDons • Investor Newsle@ers • Annual Report 6
Slide 7: Thank You
Annual Shareholder Meeting 2015 Thank You to shareholders for your continued support 7
Slide 8: Annual Shareholder Meeting 2015
Annual Shareholder Meeting 2015 88
Slide 9: Financial Highlights
Annual Shareholder Meeting 2015 FINANCIAL HIGHLIGHTS Consistent delivery of earnings growth Financial results for the year to 2015 2014 Change 31 March $M $M % Revenue 152.7 115.3 32.4% EBITDA* 23.0 17.0 35.1% Net profit aVer tax 10.2 8.0 27.5% Earnings per share (cents per share) 29.88 26.12 14.4% D
Slide 10: Key Balance Sheet Ratios
Annual Shareholder Meeting 2015 KEY BALANCE SHEET RATIOS As at 31 March 2015 2014 Total Assets $200m $149m Raw material inventory $28m $15m Net debt $26m $26.5m Net debt to EBITDA 1.1x 1.6x Net debt to equity raKo 22% 29% 10
Slide 11: Key Achievements
Annual Shareholder Meeting 2015 KEY ACHIEVEMENTS Sales growth Record net Secured honey Sales through Successful of 32% earnings of supply with direct digital Renounceable $10.2m significant honey channels Rights issue -‐ up 28% stocks available increased 55% $24.4m to realise capital raising earning
Slide 12: Sales by Region
Annual Shareholder Meeting 2015 SALES BY REGION UK/EU USA $10m $8m ASIA $47m AUS $40m NZ $48m 12
Slide 13: Sales by Region & Category
Annual Shareholder Meeting 2015 SALES BY REGION & CATEGORY Year ended March 2015 * Personal Care ** Medical 13
Slide 14: Consumer Engagement
Annual Shareholder Meeting 2015 CONSUMER ENGAGEMENT • Clearly defined consumer target of ‘Premium Rebalance’-‐ common to Asian and Western origins • Highly moDvated to achieve wellness goals via natural health soluDons • Willingness to pay a premium for brands that demonstrate integrity and have a t
Slide 15: Innovation
Annual Shareholder Meeting 2015 INNOVATION • Circa $2.8m p.a. in R&D • Partnership with The University of Auckland and part of global science network • Pioneers of advanced wound care applicaDons for medical grade honey • IdenDficaDon of key, bioacDve compounds • New product & process development – O
Slide 16: Owning and Optimising Manuka Honey
OWNING AND Annual Shareholder Meeting 2015 OPTIMISING MANUKA HONEY • Plant breeding programme, leading Manuka culDvar development • Advanced agronomic research leading to large scale planDng of Manuka • 30,000 hive apiary operaDon • Apiarist training programme • Bespoke Apiary Management System (AMS
Slide 17: Supply Chain Excellence Fresh Olive Leaf
Annual Shareholder Meeting 2015 SUPPLY CHAIN EXCELLENCE FRESH OLIVE LEAF • Approximately one million olive trees • 100% Australian grown, natural fresh olive leaf; fully integrated same day harvest to process • Natural pest management systems • Established plant selecDon processes and on site nurser
Slide 18: Taking the Long View
Annual Shareholder Meeting 2015 TAKING THE LONG VIEW • Community engagement • Sponsorship programmes • 90% of waste from Paengaroa site is recycled, reused or composted • 40,000 naDve trees planted • Bio-‐waste water system based on crushed seashells and floaDng reed beds • Research into bee health
Slide 19: Outlook 2016
Annual Shareholder Meeting 2015 OUTLOOK 2016 Focus on ConDnued OpDmising Increased earnings growth development of market and investment in supply chain channel markeDng to >35% over prior strategies and performance align consumer year partnerships opportuniDes to deliver company objecDves 19
Slide 20: Our Story
Annual Shareholder Meeting 2015 OUR STORY 20
Slide 21: Thank You
Annual Shareholder Meeting 2015 Thank You 21
Slide 22: Advancing Wound Care!
July 2015 Advancing Wound Care! A TISSUE REGENERATION COMPANY 22
Slide 23: Derma Sciences Company Overview
Derma Sciences Company Overview Devices Drugs Dressings Caring for paDents across the enDre wound care spectrum A TISSUE REGENERATION COMPANY 23
Slide 24: MEDIHONEY: Medical-Grade Honey Dressings
Worldwide exclusive license to novel, patented dressings comprised of a high percentage of Active Leptospermum Medical-Grade Honey Multiple peer reviewed studies – validate the efficacy and versatility of MEDIHONEY® in chronic wounds: Ø Supporting healing of stalled wounds! Ø Promoting autolytic d
Slide 25: A $20 Million Brand and Growing
A $20 Million brand and growing - Engaging HCPs to Continue MEDIHONEY®’S SUCCESS Ø MEDIHONEY® Novel Power Webinars:! ¯ Global webinar program lead by leading KOLs! ¯ Attracting 100’s of HCPs ! ¯ Impact to Business:! • Agile Strategic Targeting to grow brand! • Over 30% growth year on year! • Partne
Slide 26: Resolutions
Annual Shareholder Meeting 2015 RESOLUTIONS 1 Reports and Financial Statements 2 Appointment and RemuneraDon of Auditors 3-‐5 Director’s ElecDons: Re-‐elect Alan John Bougen Re-‐elect Sarah ChrisDne O@rey Elect Sarah Jane Kennedy 6 Director’s RemuneraDon 26
Slide 27: Maurice Pendergast, Independent Director
Annual Shareholder Meeting 2015 Maurice Pendergast Independent Director Since 31 July 2008 27
Slide 28: Thank You
Annual Shareholder Meeting 2015 Thank You to shareholders for your continued support 28